Toshiba releases cardiac 4D ultrasound

TriMed Staff | | Health Imaging | Diagnostic Imaging
CHICAGO—Toshiba America Medical Systems entered the 4D echocardiography market this week with the release of its new Aplio Artida ultrasound system at the American College of Cardiology (ACC) Scientific Sessions. 

The Artida meets the demands of the growing cardiac 4D market, Toshiba said. With Artida’s real-time, multi-planar reformatting capabilities, physicians can quantify global and regional LV function, including LV ejection fraction, volume and severity of regurgitation, according to the company. Arbitrary views of the heart not available in 2D imaging are also obtained that can help with surgical planning. 

Toshiba said Artida is the first ultrasound system with the ability to track myocardial motion and display myocardial motion in 3D images.

TriMed Staff

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.